PROLONGED RELEASE DOSAGE FORM OF TAPENTADOL L-(+)- TARTARIC ACID SALT

Dosage Form Providing Prolonged Release of a Salt of Tapentadol with L-(+)-Tartaric Acid Abstract: The invention relates to a tablet providing prolonged release of Tapentadol, wherein Tapentadol is present in the form of a salt with tartaric acid, in particular in the form of a salt with L-(+)-tarta...

Full description

Saved in:
Bibliographic Details
Main Authors Bertram, Ulrike, Reinhold, Ulrich, Grosse, Christian, Hartmann, Carmen
Format Patent
LanguageCroatian
English
Published 25.11.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Dosage Form Providing Prolonged Release of a Salt of Tapentadol with L-(+)-Tartaric Acid Abstract: The invention relates to a tablet providing prolonged release of Tapentadol, wherein Tapentadol is present in the form of a salt with tartaric acid, in particular in the form of a salt with L-(+)-tartaric acid. The tablet has satisfactory mechanical properties, for example, with regard to breaking strength and friability, and it can be produced under considerably facilitated tableting conditions, in particular at reduced compression force.
Bibliography:Application Number: HRP20221136T